82 results
·
18ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 3
×
Stimulator, Bone Growth, Non-Invasive
FDA Pre-Market Approval
FDA Class 3
·OL1000/OL1000 SC AND SPINALOGIC BONE BROWTH STIMULATORS
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·WALLSTENT ENDOPROSTHESIS
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·Wallstent Venous Endoprosthesis with Unistep Plus Delivery System
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·Wallstent (Venous) Endoprosthesis With Unistep Plus Delivery System
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·WALLSTENT (TIPS, ILIAC, VENOUS) ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM
Sensor, Glucose, Implanted, Non-Adjunctive Use
FDA Pre-Market Approval
FDA Class 3
·Eversense Continuous Glucose Monitoring System
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·WALLSTENT ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM (VENOUS)
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·WALLSTENT VENOUS ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·WALLSTENT ENDOPROSTHESIS
Sensor, Glucose, Implanted, Non-Adjunctive Use
FDA Pre-Market Approval
FDA Class 3
·Eversense Continuous Glucose Monitoring System
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·WALLSTENT SYSTEM (10 MM VENOUS ENDOPROSTHESIS) AND UNISTEP PLUS DELIVERY SYSTEM (12 MM VENOUS ENDOPROSTHESIS)
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·WALLSTENT (VENOUS) ENDOPROSTHESIS
Sensor, Glucose, Implanted, Non-Adjunctive Use
FDA Pre-Market Approval
FDA Class 3
·Eversense® E3 Continuous Glucose Monitoring System
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·Wallstent (Venous) Endoprosthesis With Unistep Plus Delivery System
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·WALLSTENT VENOUS ENDOPROSTHESIS
Sensor, Glucose, Implanted, Non-Adjunctive Use
FDA Pre-Market Approval
FDA Class 3
·Eversense E3 Continuous Glucose Monitoring System
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·WALLSTENT (ILIAC, TIPS, VENOUS) ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM
Sensor, Glucose, Implanted, Non-Adjunctive Use
FDA Pre-Market Approval
FDA Class 3
·Eversense E3 Continuous Glucose Monitoring System (CGM System) - Entire System, Eversense E3 Sensor, Eversense E3 Insert
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·WALLSTENT (TIPS/LLIAC/VENOUS) ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM
Stent, Central Venous
FDA Pre-Market Approval
FDA Class 3
·WALLSTENT ENDOPROSTHESIS VENOUS